A detailed history of Exane Derivatives transactions in Nutrien Ltd. stock. As of the latest transaction made, Exane Derivatives holds 130 shares of NTR stock, worth $5,967. This represents 0.01% of its overall portfolio holdings.

Number of Shares
130
Previous 6,831 98.1%
Holding current value
$5,967
Previous $710,000 98.59%
% of portfolio
0.01%
Previous 0.22%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 12, 2022

SELL
$78.95 - $114.5 $529,043 - $767,264
-6,701 Reduced 98.1%
130 $10,000
Q1 2022

Apr 22, 2022

SELL
$68.58 - $108.43 $109,042 - $172,403
-1,590 Reduced 18.88%
6,831 $710,000
Q4 2021

Jan 28, 2022

BUY
$65.93 - $76.54 $34,217 - $39,724
519 Added 6.57%
8,421 $633,000
Q3 2021

Oct 26, 2021

BUY
$57.51 - $66.26 $454,444 - $523,586
7,902 New
7,902 $512,000

Others Institutions Holding NTR

About Nutrien Ltd.


  • Ticker NTR
  • Exchange NYSE
  • Sector Basic Materials
  • Industry Agricultural Inputs
  • Shares Outstandng 538,926,016
  • Market Cap $24.7B
  • Description
  • Nutrien Ltd. provides crop inputs and services. It offers potash, nitrogen, phosphate, and sulfate products; and financial solutions. The company also distributes crop nutrients, crop protection products, seeds, and merchandise products through approximately 2,000 retail locations in the United States, Canada, South America, and Australia. In ad...
More about NTR
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.